X
17Aug

UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?

Dechert LLP | | Return|
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By: Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/

Related

New York City Broadens Employee Anti-Retaliation Protections Under NYCHRL

Not to be outdone by the New York State legislature’s flurry of eleventh-hour lawmaking (which we p...

Read More >

5 things you need to know about...shareholder activism

One - Whilst we have seen a decline in new public activist campaigns and demands since the onset of...

Read More >

Sustainable Development and Land Use Update - September 2020 #1

Bid to allow duplexes on most California lots fails after Assembly approval comes too late...Califor...

Read More >

Fraud on the Board: Material Conflicts Must Be Disclosed to the Board to Warrant Business Judgment Review

A recent decision by the Delaware Supreme Court emphasizes the importance of fully disclosing materi...

Read More >

Practical Considerations under FIDIC Contracts in Light of COVID-19

The outbreak of the coronavirus has been an unprecedented event affecting every industry, including ...

Read More >

A Forensic Accountant’s Take on Materiality

In the accounting profession, the concept of materiality in financial reporting comes from two disti...

Read More >